|
Match
|
Document |
Document Title |
|
|
US20120282346 |
BRIMONIDINE COMPOSITIONS FOR TREATING ERYTHEMA
The present invention is directed to a pharmaceutical composition including brimonidine tartrate in an amount from about 0.17 percent by weight to about 0.19 percent by weight in a... |
|
|
US20120040016 |
BRIMONIDINE COMPOSITIONS FOR TREATING ERYTHEMA
The present invention is directed to a pharmaceutical composition including brimonidine tartrate in an amount from about 0.17 percent by weight to about 0.19 percent by weight in a... |
|
|
US20110318410 |
RARE EARTH METAL COMPOUNDS, METHODS OF MAKING, AND METHODS OF USING THE SAME
Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the... |
|
|
US20110318351 |
NOVEL METHODS OF CANCER DIAGNOSIS AND THERAPY TARGETED AGAINST A CANCER STEM LINE
Improved methods for treatment of cancer which involve the targeting of slow-growing, relatively mutationally-spared cancer stem line are provided. These methods are an improvement over previous... |
|
|
US20110123628 |
RARE EARTH METAL COMPOUNDS, METHODS OF MAKING, AND METHODS OF USING THE SAME
Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the... |
|
|
US20100215643 |
ANTI-INFECTIVE FUNCTIONALIZED SURFACES AND METHODS OF MAKING SAME
Devices are provided which are functionalized to include surface regions having anti-infective agents. Methods are provided for functionalizing various material surfaces to include active surface... |
|
|
US20090061020 |
Brimonidine Compositions for Treating Erythema
The present invention is directed to a pharmaceutical composition including brimonidine tartrate in an amount from about 0.17 percent by weight to about 0.19 percent by weight in a... |
|
|
US20090017133 |
PHARMACEUTICAL FORMULATION COMPRISING LANTHANUM COMPOUNDS
This invention relates to a chewable lanthanum formulation comprising a pharmaceutically effective amount of a lanthanum compound; and at least one chewable pharmaceutically acceptable excipient.... |
|
|
US20080305107 |
NOVEL METHODS OF CANCER DIAGNOSIS AND THERAPY TARGETED AGAINST A CANCER STEM LINE
Improved methods for treatment of cancer which involve the targeting of slow-growing, relatively mutationally-spared cancer stem line are provided. These methods are an improvement over previous... |
|
|
US20140287061 |
IN-SITU CROSS-LINKABLE POLYMERIC COMPOSITIONS AND METHODS THEREOF
A biocompatible polymeric composition for cross-linking in-situ in a wound is disclosed comprising 1) one or more polyanionic polymers such as alginates or hyaluronates, able to be cross-linked... |
|
|
US20100278910 |
RARE EARTH METAL COMPOUNDS, METHODS OF MAKING, AND METHODS OF USING THE SAME
Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the... |
|
|
US20090053322 |
RARE EARTH METAL COMPOUNDS, METHODS OF MAKING, AND METHODS OF USING THE SAME
Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the... |
|
|
US20080299222 |
Bioactive agrichemical compositions and use thereof
Bioactive agrichemical concentrates and compositions having improved bioactivity comprising combinations of acid solutions and conventional bioactive agrichemical actives or formulations. |
|
|
US20080020063 |
ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic... |
|
|
US20070298123 |
ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE
The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic... |
|
|
US20060193904 |
Liposome loading with metal ions
This invention relates to encapsulation of drugs and other agents into liposomes. |
|
|
US20160184387 |
COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT
Provided are non-NHE3-binding agents having activity as phosphate transport/uptake inhibitors in the gastrointestinal tract, including in the small intestine, methods for their use as therapeutic... |
|
|
US20150238477 |
Method of Treating Lung Adenocarcinoma
This invention is directed to the treatment of cancer in a patient, particularly a patient with lung adenocarcinoma, and more particularly a patient with KIF5B-RET fusion-positive non-small cell... |
|
|
US20140205642 |
ANTIMICROBIAL SUBSTRATE
A method of preparing antimicrobial-containing polymeric products is provided, the method involving electrospinning a dispersion comprising a dispersible polymer, a fiberizing polymer, and one or... |
|
|
US20130022660 |
DRUG DELIVERY SYSTEM FOR THE PREVENTION OF CEREBRAL VASOSPASM
The present invention relates to the treatment and prevention of vasospasm. The present invention provides a system for treating a cerebral vasospasm in a human utilizing a pharmaceutical... |
|
|
US20120328681 |
CERIA FOR USE AS AN ANTIMICROBIAL BARRIER AND DISINFECTANT IN A WOUND DRESSING
The present invention relates to protecting a human from an infection using a disinfecting agent as described herein and a method for use thereof, more particularly to a rare earth-containing... |
|
|
US20110002971 |
CERIA FOR USE AS AN ANTIMICROBIAL BARRIER AND DISINFECTANT IN A WOUND DRESSING
The present invention relates to protecting a human from an infection using a disinfecting agent as described herein and a method for use thereof, more particularly to a rare earth-containing... |
|
|
US20080226735 |
RARE EARTH METAL COMPOSITIONS FOR TREATING HYPERPHOSPHATEMIA AND RELATED METHODS
Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the... |
|
|
US20080050452 |
METAL-CONTAINING FORMULATIONS AND METHODS OF USE
Metal-containing materials, as well as their preparation, formulations, and use are disclosed. |
|
|
US20060127445 |
Anti-angiogenic compositions and methods of use
The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic... |
|
|
US20060002837 |
Processes for making rare earth metal oxycarbonates
Rare earth metal compounds, particularly lanthanum, cerium, and yttrium, are formed as porous particles and are effective in binding metals, metal ions, and phosphate. A method of making the... |
|
|
US20050158393 |
Colloidal metal labeled microparticles and methods for producing and using the same
The present invention relates to polymeric materials that are labeled with colloidal metals, preferably colloidal gold, to processes for producing the labeled polymeric material, and to methods of... |
|
|
US20050025805 |
Osmium compounds for reduction of adverse inflammation
Reduction of adverse inflammatory reaction to an implant or a transplant, or following trauma or infection, is achieved through catalysis of dismutation of the superoxide radical anion by an... |
|
|
US20100119602 |
PHOSPHATE BINDER WITH REDUCED PILL BURDEN
The present invention is generally directed to compositions and formulations that can be used for the treatment of diseases such as End Stage Renal Disease (“ESRD”) and Chronic Renal Insufficiency... |
|
|
US20100119576 |
USE OF ONE OR MORE OF THE ELEMENTS FROM THE GROUP YTTRIUM, NEODYMIUM AND ZIRCONIUM, AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN THOSE ELEMENTS
A method of treating a patient includes the medical use of one or more of the elements from the group yttrium, neodymium and zirconium, pharmaceutical formulations which contain said elements and... |
|
|
US20100034899 |
USE OF ONE OR MORE OF THE ELEMENTS FROM THE GROUP YTTRIUM, NEODYMIUM AND ZIRCONIUM, AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN THOSE ELEMENTS
A method of treating a patient includes the medical use of one or more of the elements from the group yttrium, neodymium and zirconium, pharmaceutical formulations which contain said elements and... |
|
|
US20080063642 |
Methods of using (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of certain hematologic disorders
Methods of treating, preventing or managing hematologic disorders, such as leukemia are disclosed. The methods encompass the administration of SNS-595. Also provided are methods of treatment using... |
|
|
US20070231408 |
Colloidal metal compositions and methods
The present invention comprises compositions and methods for delivery systems of agents, including therapeutic compounds, pharmaceutical agents, drugs, detection agents, nucleic acid sequences and... |
|
|
US20060134225 |
Phosphate binder with reduced pill burden
The present invention is generally directed to compositions and formulations that can be used for the treatment of diseases such as End Stage Renal Disease (“ESRD”) and Chronic Renal Insufficiency... |
|
|
US20130071489 |
METHODS AND COMPOSITIONS FOR SAFE AND EFFECTIVE TREATMENT OF ERYTHEMA
Improved methods and compositions for safe and effective treatment of erythema or a symptom associated with erythema in a subject are described. The methods involve topically applying to an... |
|
|
US20110171188 |
NON-THERMAL PLASMA FOR WOUND TREATMENT AND ASSOCIATED APPARATUS AND METHOD
The invention relates to a non-thermal plasma for treatment of a surface, particularly for the treatment of a wound (1), wherein the plasma comprises a partially ionized carrier gas and at least... |
|
|
US20110064712 |
Dietary Supplement Compositions and Methods of Making and Using the Same
Dietary supplement compositions are disclosed. Methods of making and using dietary supplement compositions are also disclosed. |
|
|
US20100266649 |
Gel Technology Suitable for Use in Cosmetic Compositions
A gel system comprising a fractal network of nanoparticles and macroscopic particles is disclosed. The gel system is capable of forming an “optical gel” effective to blurrfine lines and wrinkles... |
|
|
US20080187602 |
STABILIZED LANTHANUM CARBONATE COMPOSITIONS
Stabilized lanthanum carbonate compositions containing a monosaccharide or disaccharide stabilizing agent are disclosed. Subjects having hyperphosphatemia can be treated by administering a... |
|
|
US20050186288 |
Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions
Disclosed is a topical method for providing highly effective analgesic, anti-inflammatory, antimicrobial and tissue-regenerating activities for the hitherto most effective prophylaxis and... |
|
|
US20050059031 |
Method for enhancing transport of semiconductor nanocrystals across biological membranes
Semiconductor nanoparticle complexes comprising semiconductor nanoparticles in association with cationic polymers are described. Also described are methods for enhancing the transport of... |
|
|
US20110262556 |
SILVER/WATER, SILVER GELS AND SILVER-BASED COMPOSITIONS; AND METHODS FOR MAKING AND USING THE SAME
We disclose a colorless composition comprising metal particles (e.g., silver nanoparticles) and water, wherein said particles comprise an interior of elemental metal (e.g., silver) and an exterior... |
|
|
US20100297206 |
Antimicrobial Upconversion System
Antimicrobial articles, systems, and methods may be used for killing, inactivating, and/or inhibiting microorganisms. The antimicrobial articles and systems utilize up-conversion luminescence... |
|
|
US20070286877 |
MULTI-FUNCTIONAL PROTECTIVE TEXTILES AND METHODS FOR DECONTAMINATION
A reactive and adsorptive (i.e., multi-functional protective) textile and methods for constructing and using same which possess at least chemically reactive and biocidal properties. Nanoparticles... |
|
|
US20070264303 |
Coating for medical devices comprising an inorganic or ceramic oxide and a therapeutic agent
The invention relates generally to an implantable medical device for delivering a therapeutic agent to the body tissue of a patient, and a method for making such a medical device. In particular,... |
|
|
US20140342017 |
Microporous Zirconium Silicate for the Treatment of Hyperkalemia
The present invention relates to novel microporous zirconium silicate compositions that are formulated to remove toxins, e.g. potassium ions, from the gastrointestinal tract at an elevated rate... |
|
|
US20100233222 |
COSMETIC SKIN TREATMENT PROCESS
Cosmetic treatment processes include application of cosmetic compositions to a skin surface by spraying, such compositions including at least one filler in a physiologically acceptable medium, the... |
|
|
US20090053323 |
Aqueous disinfectants and sterilants including transition metals
The present invention is drawn to disinfectant or sterilant compositions, which are human safe, e.g., food grade or food safe. In one embodiment, an aqueous disinfectant or sterilant composition... |
|
|
US20060051407 |
Method of treating ischemia-reperfusion injury
The present invention relates to methods and compositions designed for the prevention, reduction, treatment or management of ischemia-reperfusion injury. The methods of the invention comprise the... |
|
|
US20150196592 |
MICROPOROUS ZIRCONIUM SILICATE FOR THE TREATMENT OF HYPERKALEMIA
The present invention relates to novel microporous zirconium silicate compositions that are formulated to remove toxins, e.g. potassium ions, from the gastrointestinal tract at an elevated rate... |